Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
PMID 35985340)
Both contain liraglutide as their active ingredient
In the STEP 1 extension trial, participants regained approximately two-thirds of their weight loss after stopping semaglutide
Heres what I found: Bariatric surgery leads to greater, more durable weight loss and comorbidity reduction compared to GLP-1s GLP-1s offer substantial but less sustained comorbidity benefit with higher discontinuation rates (up to 50% at 35 yrs) GLP-1s do not eliminate the need for bariatric surgery in severe obesity Total weight loss trends higher for bariatric surgery, and real-world GLP-1 effectiveness is generally lower than clinical trial results (a significant finding that deserves its own post) Bariatric surgery is generally more effective than GLP-1s for long-term diabetes remission and cardiovascular risk reduction GLP-1s are associated with higher ongoing costs and are less cost-effective than bariatric surgery long-term The take home: GLP-1s are a valuable addition but dont replace bariatric procedures for patients with severe obesity or those requiring durable, substantial weight loss with co-morbidity reduction
Subscription pricing for a two-month supply drops the cost to $44.96 (10% off the regular $49.96)
US$ 20.20
US$ 20.89
US$ 26.91
US$ 23.75
US$ 21.14
US$ 23.73
US$ 28.19
US$ 24.21
